You are here

Sanofi

Drugmakers push forward on large-scale production of coronavirus vaccines

Drugmakers push forward on large-scale production of coronavirus vaccines

BioPharma Dive

Operation Warp Speed

Moderna Therapeutics

Flag link:

Here come the tortoises: In the race for a Covid-19 vaccine, slow starters could still win out

Here come the tortoises: In the race for a Covid-19 vaccine, slow starters could still win out

Stat

Moderna Therapeutics

Flag link:

Sanofi, GSK sign agreements with Government of Canada to supply 72 million doses of adjuvanted Covid-19 vaccine

Sanofi, GSK sign agreements with Government of Canada to supply 72 million doses of adjuvanted Covid-19 vaccine

Pharmaceutical Business Review

Flag link:

ESMO: Regeneron and Sanofi gun for Libtayo in first-line NSCLC with fresh survival stats

ESMO: Regeneron and Sanofi gun for Libtayo in first-line NSCLC with fresh survival stats

Fierce Pharma

non-small cell lung cancer

Flag link:

Sanofi/Regeneron’s Libtayo set for new skin cancer use

Sanofi/Regeneron’s Libtayo set for new skin cancer use

Pharmaforum

clinical trials

Flag link:

Sanofi backs Escient's $77.5M round as it kick-starts first clinical test

Sanofi backs Escient's $77.5M round as it kick-starts first clinical test

Fierce Biotech

Flag link:

Sanofi, Regeneron get FDA breakthrough therapy status for Dupixent to treat eosinophilic esophagitis

Sanofi, Regeneron get FDA breakthrough therapy status for Dupixent to treat eosinophilic esophagitis

Pharmaceutical Business Review

eosinophilic esophagitis

breakthrough status

Flag link:

Sanofi's hemophilia drug comes into focus as delays hit a key competitor

Sanofi's hemophilia drug comes into focus as delays hit a key competitor

BioPharma Dive

Flag link:

COVID-19 vaccine CEOs vow to wait for phase 3 data before filing for approval

COVID-19 vaccine CEOs vow to wait for phase 3 data before filing for approval

Fierce Pharma

Operation Warp Speed

Moderna Therapeutics

Flag link:

Sanofi’s later-stage trials hardest hit by COVID-19: Report

Sanofi’s later-stage trials hardest hit by COVID-19: Report

Fierce Biotech

clinical trials

Flag link:

Big pharma spinouts grow up

Big pharma spinouts grow up

EP Vantage

Flag link:

Sanofi, GSK, racing to catch up, begin their first human study of coronavirus vaccine

Sanofi, GSK, racing to catch up, begin their first human study of coronavirus vaccine

BioPharma Dive

clinical trials

Flag link:

Sanofi Halts Kevzara Tests for Covid as Drug Fails to Help

Sanofi Halts Kevzara Tests for Covid as Drug Fails to Help

Bloomberg

clinical trials

Flag link:

ESC: Amgen chases pediatric use for cholesterol-busting PCSK9 med Repatha

ESC: Amgen chases pediatric use for cholesterol-busting PCSK9 med Repatha

Fierce Pharma

Flag link:

Paul Hudson is more confident in Sanofi's ability to produce a Covid-19 vaccine — report

Paul Hudson is more confident in Sanofi's ability to produce a Covid-19 vaccine — report

Endpoints

Flag link:

Sanofi, seeking control of key drug, to buy Principia for $3.7B

Sanofi, seeking control of key drug, to buy Principia for $3.7B

BioPharma Dive

Principia Biopharma

multiple sclerosis

Flag link:

Five Top Drugmakers Reveal List vs. Net Price Gaps

Five Top Drugmakers Reveal List vs. Net Price Gaps

Drug Channels

Flag link:

Pfizer, Merck, and Others See a Slowdown in Vaccine Sales, but Anticipate an Autumn Rebound

Pfizer, Merck, and Others See a Slowdown in Vaccine Sales, but Anticipate an Autumn Rebound

Motley Fool

Flag link:

Sanofi, GlaxoSmithKline disclose DOJ investigation into Zantac after recalls

Sanofi, GlaxoSmithKline disclose DOJ investigation into Zantac after recalls

Fierce Pharma

product recalls

False Claims Act

Flag link:

Sanofi faces manslaughter charges in France over yearslong Depakine probe

Sanofi faces manslaughter charges in France over yearslong Depakine probe

Fierce Pharma

Flag link:

Pages